EU approves Pfizer-BioNTech coronavirus vaccine

The EU’s drug regulator authorised the Pfizer-BioNTech coronavirus vaccine on Monday, saying there was no evidence it would not work against a new strain found mainly in Britain.The European Medicines Agency said the “historic” step paved the way for vaccinations to finally start within days across the 27-nation European Union, where cases of the disease are surging.The Amsterdam-based regulator moved the decision forward from December 29 under pressure from EU governments, after Britain and…

Read the original article at South China Morning Post